Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4648430
Max Phase: Preclinical
Molecular Formula: C28H33Cl2F3N6O4S
Molecular Weight: 604.66
Molecule Type: Unknown
Associated Items:
ID: ALA4648430
Max Phase: Preclinical
Molecular Formula: C28H33Cl2F3N6O4S
Molecular Weight: 604.66
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(-c2nc(NC(=O)c3cnc(N4CCC(C(=O)O)CC4)cn3)sc2CN2CCC[C@H]2C)cc1C(F)(F)F.Cl.Cl
Standard InChI: InChI=1S/C28H31F3N6O4S.2ClH/c1-16-4-3-9-37(16)15-22-24(18-5-6-21(41-2)19(12-18)28(29,30)31)34-27(42-22)35-25(38)20-13-33-23(14-32-20)36-10-7-17(8-11-36)26(39)40;;/h5-6,12-14,16-17H,3-4,7-11,15H2,1-2H3,(H,39,40)(H,34,35,38);2*1H/t16-;;/m1../s1
Standard InChI Key: RCFGOTOPFKCKNY-GGMCWBHBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.66 | Molecular Weight (Monoisotopic): 604.2080 | AlogP: 5.17 | #Rotatable Bonds: 8 |
Polar Surface Area: 120.78 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.24 | CX Basic pKa: 8.36 | CX LogP: 2.05 | CX LogD: 2.02 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.36 | Np Likeness Score: -1.67 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):